 |
 |
 |
|
Characteristics, treatment patterns, and viral load for treatment-experienced people living with HIV and switching to an MTR or STR ARV after 2018
|
|
|
EACS 2021 Oct 27-30
B. Chastek1, A. Anderson1, J. Gruber2, S. Majethia2, W. Zachry2, D. Mezzio2, A. Colson3
1Optum, Eden Prairie, United States, 2Gilead Sciences, Foster City, United States, 3Community Research Initiative (CRI), Boston, United States








|
|
|
 |
 |
|
|